Acute modafinil exposure reduces daytime sleepiness in abstinent methamphetamine-dependent volunteers

International Journal of Neuropsychopharmacology

Volumn 15, Issue 9, 2012, Pages 1241-1249

  Mahoney, James J ^a,b   Jackson, Brian J ^a,b   Kalechstein, Ari D ^a,b   De La Garza, Richard ^a,b   Chang, Lee C ^a,b   Newton, Thomas F ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Methamphetamine; modafinil; sleep

Indexed keywords

METHAMPHETAMINE; MODAFINIL; PLACEBO;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MALE; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; SINGLE DRUG DOSE; SLEEP; VISUAL ANALOG SCALE; VOLUNTEER;

ADULT; AMPHETAMINE-RELATED DISORDERS; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; POLYSOMNOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; SLEEP; SLEEP DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 84871518963     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001805     Document Type: Article

References (41)

1. Arnulf I, Homeyer P, Garma L, Whitelaw WA, et al. (1997). Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients. Respiration 64, 159-161.
2. Beck AT, Steer RA, Ball R, Ranieri W (1996). Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. Journal of Personality Assessment 67, 588-597.
3. Besset A, Tafti M, Villemin E, Billiard M (1993). The effects of modafinil (300 mg) on sleep, sleepiness and arousal in narcoleptic patients. Neurophysiologie Clinique 23, 47-60.
4. Buysse DJ, Reynolds III CF, Monk TH, Berman SR, et al. (1989). The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Journal of Psychiatric Research 28, 193-213.
5. Carskadon MA, Dement WC (1982). The multiple sleep latency test : what does it measure? Sleep 2, 67-72.
6. Cephalon (2004). Provigil Product Information and Medication Guide. Frazer, PA: Cephalon.
7. Cho AK, Melega WP, Kuczenski R, Segal DS (2001). Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 39, 161-166.
8. De La Garza II, R, Zorick T, London ED, Newton TF (2010). Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug and Alcohol Dependence 106, 173-180.
9. Galloway GP, Singleton EG, Buscemi R, Baggott MJ, et al. (2010). Methamphetamine treatment project corporate authors: an examination of drug craving over time in abstinent methamphetamine users. American Journal on Addictions 6, 510-514.
10. Gawin F, ME K, Ellinwood E (1994). Stimulants. In : Galanter M, Kleber H (Eds.), Textbook of Substance Abuse Treatment. Washington, DC: American Psychiatric Press.
11. Gawin FH, Kleber HD (1986). Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations. Archives of General Psychiatry 43, 107-113.
12. Ghahremani DG, Tabibnia G, Monterosso J, Hellemann, et al. (2011). Effect of modafinil on learning and task-related brain activity in methamphetaminedependent and healthy individuals. Neuropsychopharmacology 36, 950-959.
13. Hart CL, Ward AS, Haney M, Nasser J, et al. (2003). Methamphetamine attenuates disruptions in performance and mood during simulated night-shift work. Psychopharmacology (Berlin) 169, 42-51.
14. Johns MW (1991). A new method for measuring daytime sleepiness : the Epworth sleepiness scale. Sleep 14, 540-545.
15. Johnson LC, Spinweber CL, Gomez SA (1990). Benzodiazepines and caffeine: effect on daytime sleepiness, performance, and mood. Psychopharmacology (Berlin) 101, 160-167.
16. McCann UD, Kuwabara H, Kumar A, Palermo M, et al. (2007). Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 62, 91-100.
17. McCann UD, Wong DF, Yokoi F, Villemagne V, et al. (1998). Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. Journal of Neuroscience 18, 8417-8422.
18. McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, et al. (2005). The nature, time course and severity of methamphetamine withdrawal. Addiction 100, 1320-1329.
19. McGregor C, Srisurapanont M, Mitchell A, Wickes W, et al. (2008). Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal : a comparison of mirtazapine and modafinil with treatment as usual. Journal of Substance Abuse Treatment 35, 334-342.
20. Madras BK, Xie Z, Lin Z, Jassen A, et al. (2006). Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. Journal of Pharmacology and Experimental Therapeutics 319, 561-569.
21. Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ (2005). Implications of chronic methamphetamine use : a literature review. Harvard Review of Psychiatry 13, 141-154.
22. Morgan PT, Malison RT (2007). Cocaine and sleep : early abstinence. Scientific World Journal 7, 223-230.
23. Morgan PT, Pace-Schott E, Pittman B, Stickgold R, et al. (2010). Normalizing effects of modafinil on sleep in chronic cocaine users. American Journal of Psychiatry 3, 331-340.
24. Newton TF, Kalechstein AD, Duran S, Vansluis N, et al. (2004). Methamphetamine abstinence syndrome : preliminary findings. American Journal on Addictions 13, 248-255.
25. NSF (2009). Aging and sleep-poll data (http://www.sleepfoundation.org/ article/topics/aging-andsleep-poll-data). Accessed December 2011.
26. Prosise GL, Bonnet MH, Berry RB, Dickel MJ (1994). Effects of abstinence from smoking on sleep and daytime sleepiness. Chest 105, 1136-1141.
27. Rechtschaffen A, Kales A (1968). A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Bethesda: National Institute for Neurological Disorders and Blindness.
28. Robertson Jr. P, Hellriegel ET (2003). Clinical pharmacokinetic profile of modafinil. Clinical Pharmacokinetics 42, 123-137.
29. Rothschild AJ (1988). Biology of depression. Medical Clinics of North America 72, 765-790.
30. Sekine Y, Minabe Y, Ouchi Y, Takei N, et al. (2003). Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. American Journal of Psychiatry 160, 1699-1701.
31. Sekine Y, Ouchi Y, Takei N, Yoshikawa E, et al. (2006). Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Archives of General Psychiatry 63, 90-100.
32. Shappell SA, Kearns GL, Valentine JL, Neri DF, et al. (1996). Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man. Journal of Clinical Pharmacology 36, 1051-1063.
33. Shearer WT, Reuben JM, Mullington JM, Price NJ, et al. (2001). Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. Journal of Allergy and Clinical Immunology 107, 165-170.
34. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, et al. (1997). Reliability and validity of the MINI International Neuropsychiatric Interview (M.I.N.I.) : according to the SCID-P. European Psychiatry 12, 232-241.
35. Sofuoglu M, Sewell RA (2009). Norepinephrine and stimulant addiction. Addiction Biology 14, 119-29.
36. Tobin ML (2007). Why choose modafinil for excessive daytime sleepiness? Issues in Mental Health Nursing 28, 313-317.
37. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, et al. (1997). Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. Journal of Clinical Endocrinology & Metabolism 82, 1313-1316.
38. Volkow ND, Chang L, Wang GJ, Fowler JS, et al. (2001). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry 158, 377-382.
39. Volkow ND, Fowler JS, Logan J, Alexoff D, et al. (2009). Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. Journal of the American Medical Association 301, 1148-1154.
40. WeddingtonWW, Brown BS, Haertzen CA, Cone EJ, et al. (1990). Changes in mood, craving and sleep during acute abstinence reported by male cocaine addicts. NIDA Research Monograph 105, 453-454.
41. Wong YN, King SP, Simcoe D, Gorman S, et al. (1999). Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects. Journal of Clinical Pharmacology 39, 281-288.